Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Prognostic and predictive value of nuclear imaging in endocrine oncology.

Treglia G, Goichot B, Giovanella L, Hindié E, Jha A, Pacak K, Taïeb D, Walter T, Imperiale A.

Endocrine. 2019 Nov 16. doi: 10.1007/s12020-019-02131-4. [Epub ahead of print] Review.

PMID:
31734779
2.

Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.

Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P.

Ann Nucl Med. 2019 Sep;33(9):697-707. doi: 10.1007/s12149-019-01378-1. Epub 2019 Jun 15.

PMID:
31214959
3.

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.

Hescot S, Curras-Freixes M, Deutschbein T, van Berkel A, Vezzosi D, Amar L, de la Fouchardière C, Valdes N, Riccardi F, Do Cao C, Bertherat J, Goichot B, Beuschlein F, Drui D, Canu L, Niccoli P, Laboureau S, Tabarin A, Leboulleux S, Calsina B, Libé R, Faggiano A, Schlumberger M, Borson-Chazot F, Mannelli M, Gimenez-Roqueplo AP, Caron P, Timmers HJLM, Fassnacht M, Robledo M, Borget I, Baudin E; European Network for the Study of Adrenal Tumors (ENS@T).

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374. doi: 10.1210/jc.2018-01968.

PMID:
30715419
4.

Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.

Buffet A, Ben Aim L, Leboulleux S, Drui D, Vezzosi D, Libé R, Ajzenberg C, Bernardeschi D, Cariou B, Chabolle F, Chabre O, Darrouzet V, Delemer B, Desailloud R, Goichot B, Esvant A, Offredo L, Herman P, Laboureau S, Lefebvre H, Pierre P, Raingeard I, Reznik Y, Sadoul JL, Hadoux J, Tabarin A, Tauveron I, Zenaty D, Favier J, Bertherat J, Baudin E, Amar L, Gimenez-Roqueplo AP; French Group of Endocrine Tumors (GTE) and COMETE Network.

J Clin Endocrinol Metab. 2019 Apr 1;104(4):1109-1118. doi: 10.1210/jc.2018-02411.

PMID:
30698717
5.

18F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma.

Helali M, Moreau M, Le Fèvre C, Heimburger C, Bund C, Goichot B, Veillon F, Hubelé F, Charpiot A, Noel G, Imperiale A.

Cancers (Basel). 2019 Jan 8;11(1). pii: E54. doi: 10.3390/cancers11010054.

6.

Early 18F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma.

Leroy-Freschini B, Amodru V, Addeo P, Sebag F, Vix M, Brunaud L, Klein M, Bahougne T, Bachellier P, Castinetti F, Goichot B, Chevalier E, Taieb D, Imperiale A.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):686-695. doi: 10.1007/s00259-018-4245-3. Epub 2019 Jan 7.

PMID:
30617961
7.

Macrovascular venous invasion of pancreatic neuroendocrine tumours: impact on surgical outcomes and survival.

Addeo P, d'Alessandro A, Averous G, Imperiale A, Faitot F, Goichot B, Bachellier P.

HPB (Oxford). 2019 Jun;21(6):653-661. doi: 10.1016/j.hpb.2018.10.010. Epub 2018 Dec 3.

PMID:
30522946
8.

The Role of Endoscopic Endonasal Approach in the Multimodal Management of Giant Pituitary Adenoma: Case Report and Literature Review.

Chibbaro S, Ganau M, Gubian A, Scibilia A, Todeschi J, Riehm S, Moliere S, Debry C, Goichot B, Proust F, Cebula H.

Asian J Neurosurg. 2018 Jul-Sep;13(3):888-892. doi: 10.4103/ajns.AJNS_97_18.

9.

Diagnostic procedure in suspected Graves' disease.

Goichot B, Leenhardt L, Massart C, Raverot V, Tramalloni J, Iraqi H; Consensus work-group.

Ann Endocrinol (Paris). 2018 Dec;79(6):608-617. doi: 10.1016/j.ando.2018.08.002. Epub 2018 Aug 18. Review.

PMID:
30220410
10.

18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.

Heimburger C, Bund C, Addeo P, Goichot B, Imperiale A.

Clin Nucl Med. 2018 Sep;43(9):e324-e325. doi: 10.1097/RLU.0000000000002202.

PMID:
30052596
11.

Metabolic Response to BRAF-MEK Combination Therapy in Cecal Neuroendocrine Carcinoma With BRAFV600E Mutation and Refractory Lactic Acidosis.

Imperiale A, Latgé A, Schaff-Wendling F, Goichot B, Kurtz JE, Malouf GG.

Clin Nucl Med. 2018 Sep;43(9):701-702. doi: 10.1097/RLU.0000000000002231.

PMID:
30036245
12.

18F-FDOPA PET/CT of Nonfunctioning Paraganglioma of the Gastroepiploic Pedicle.

Leroy Freschini B, Addeo P, Averous G, Goichot B, Bachellier P, Imperiale A.

Clin Nucl Med. 2018 Sep;43(9):e326-e328. doi: 10.1097/RLU.0000000000002185.

PMID:
30004936
13.

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).

Rault-Petit B, Do Cao C, Guyétant S, Guimbaud R, Rohmer V, Julié C, Baudin E, Goichot B, Coriat R, Tabarin A, Ramos J, Goudet P, Hervieu V, Scoazec JY, Walter T.

Ann Surg. 2019 Jul;270(1):165-171. doi: 10.1097/SLA.0000000000002736.

PMID:
29557879
14.

A Persistent Migrating Rash.

Addeo P, Goichot B, Bachellier P.

Gastroenterology. 2018 Sep;155(3):e7-e8. doi: 10.1053/j.gastro.2018.02.039. Epub 2018 Mar 13. No abstract available.

PMID:
29549039
15.

Preoperative Imaging with 18F-FDOPA PET/CT for Small Bowel Neuroendocrine Tumors.

Addeo P, Bachellier P, Goichot B, Imperiale A.

J Gastrointest Surg. 2018 Nov;22(11):1992-1994. doi: 10.1007/s11605-018-3729-6. Epub 2018 Mar 12. No abstract available.

PMID:
29532361
16.

SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.

Reznik Y, Barat P, Bertherat J, Bouvattier C, Castinetti F, Chabre O, Chanson P, Cortet C, Delemer B, Goichot B, Gruson D, Guignat L, Proust-Lemoine E, Sanson MR, Reynaud R, Boustani DS, Simon D, Tabarin A, Zenaty D.

Ann Endocrinol (Paris). 2018 Feb;79(1):1-22. doi: 10.1016/j.ando.2017.12.001. Epub 2018 Jan 12.

17.

The Added Diagnostic Value of 18F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.

Addeo P, Poncet G, Goichot B, Leclerc L, Brigand C, Mutter D, Romain B, Namer IJ, Bachellier P, Imperiale A.

J Gastrointest Surg. 2018 Apr;22(4):722-730. doi: 10.1007/s11605-017-3645-1. Epub 2017 Dec 12.

PMID:
29235002
18.

Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality.

Chabre O, Goichot B, Zenaty D, Bertherat J.

Ann Endocrinol (Paris). 2017 Dec;78(6):490-494. doi: 10.1016/j.ando.2017.10.010. Epub 2017 Nov 27. Review.

PMID:
29174931
19.

Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis.

Chanson P, Guignat L, Goichot B, Chabre O, Boustani DS, Reynaud R, Simon D, Tabarin A, Gruson D, Reznik Y, Raffin Sanson ML.

Ann Endocrinol (Paris). 2017 Dec;78(6):495-511. doi: 10.1016/j.ando.2017.10.005. Epub 2017 Nov 23. Review.

PMID:
29174200
20.

Upper and lower gastrointestinal endoscopies in patients over 85 years of age: Risk-benefit evaluation of a longitudinal cohort.

Clere-Jehl R, Schaeffer M, Vogel T, Kiesmann M, Pasquali JL, Andres E, Bourgarit A, Goichot B.

Medicine (Baltimore). 2017 Nov;96(44):e8439. doi: 10.1097/MD.0000000000008439.

Supplemental Content

Loading ...
Support Center